Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 26Myelodysplastic Syndromes 13Recurrence 4Leukemia, Myelomonocytic, Chronic 4Lymphoma, Large B-Cell, Diffuse 3Leukemia 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma 2Thrombocythemia, Essential 1Systemic Mastocytosis With an Associated Hematologic Neoplasm 1Primary Myelofibrosis 1Polycythemia Vera 1Ovarian Neoplasms 1Neoplasms 1Neoplasm, Residual 1Myeloproliferative Disorders 1Myeloid Malignancies 1Myelodysplastic-Myeloproliferative Diseases 1Lymphodepleting Chemotherapy 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Biphenotypic, Acute 1Hypomethylating Agent 1Human Papillomavirus-Negative Neck Squamous Cell Carcinoma 1Hodgkin Disease 1Hematologic Neoplasms 1Congenital Bone Marrow Failure Syndromes 1Burkitt Lymphoma 1Anemia, Refractory, with Excess of Blasts 1Accelerated Phase Myeloproliferative Neoplasm 1

Interventions

decitabine and cedazuridine drug combination 1avapritinib 1Decitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Systemic Mastocytosis With an Associated Hematologic Neoplasm × Decitabine × Clear all
NCT06327685 2026-04-01

Avapritinib With Decitabine in Patients With SM-AHN

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Recruiting
34 enrolled
MyeloidOther hematologic neoplasm

Systemic Mastocytosis With an Associated Hematologic Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡